Latest medical news · page 268

FDA expands Wegovy (semaglutide) approval

Efficacy supplement (new or revised indication). solution, subcutaneous. Sponsor: Novo

FDA expands Padcev (enfortumab vedotin-ejfv) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Astellas

Academy considers next steps after unfavorable PSLF program final rule

FDA expands Retevmo (selpercatinib) approval

Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Eli Lilly And Co

FDA expands Retevmo (selpercatinib) approval

Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Eli Lilly And Co

FDA expands Koselugo (selumetinib sulfate) approval

Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Astrazeneca

Meet Anita Ravi, MD, L’Oréal honoree, family physician and advocate

Episode 241 -- November 2025 -- Part 1 AFP: American Family Physician

Disorders of puberty (1:30), caregiver-targeted interventions for childhood caries (5:40), perfluorohexyloctane ophthalmic solution (8:00), iron deficiency anemia (12:50), amiloride vs spironolactone (18:00), and trauma-informed care (20:00).

Palliative Care: A Family Perspective

Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.

AAFP type 1 diabetes framework charts ‘a way forward’

Physician reentry: How to overcome challenges of returning to clinical practice

Final 2026 MPFS brings primary care payment boost and other wins

Episode 68 - Rita Figueira & Andreas Hoefer - A Network of Laboratory Excellence

On today's episode, we discuss EU Reference Laboratories (EURLs) with Andreas Hoefer from ECDC and Rita Figuera from the European Commission’s DG SANTE. They explain the vital role these laboratories play, how both organisations support national labs, ensure test results are reliable across borders, and strengthen Europe's ability to respond to health threats as part of the European Health Union. Find all information on the EU Reference Laboratories for public health on ⁠EC pages⁠ . Learn how ECDC works with EU Reference Laboratories on the ECDC portal . Interested in ECDC and what we do?…

FDA expands Linzess (linaclotide) approval

Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Abbvie

What You May Have Missed in 2024: Part 3

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Episode 240 -- October 2025 -- Part 2 AFP: American Family Physician

Overuse of colorectal cancer screening (1:30), depression practice guideline (3:20), anticoagulation in hospitalized patients with COVID-19 (6:10), slipped capital femoral epiphysis (7:50), left atrial appendage closure in atrial fibrillation after ablation (11:30), and venous thromboembolism (14:00).

FDA expands Winrevair (sotatercept-csrk) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Merck Sharp Dohme

Episode 67 - Angeliki Melidou - Winter Viruses: The triple threat explained

In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC's Principal Expert in Respiratory Viruses - Angeliki Melidou. Angeliki explores the impact of viruses like influenza, RSV, and COVID-19, the importance of vaccination, and practical measures to protect both individuals and healthcare systems. Tune in for insights on how to navigate the winter months safely. Read about the current respiratory disease situation on erviss.org . For more information about ECDC in general visit ecdc.europa.eu and follow our social media for the latest news.

FDA expands Vyepti (eptinezumab-jjmr) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Lundbeck Seattle Biopharmaceuticals, Inc.

What You May Have Missed in 2024 - Part 2

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

FDA expands Xeljanz (tofacitinib citrate) approval

Efficacy supplement (new or revised indication). solution, oral. Sponsor: Pfizer

FDA expands Xeljanz (tofacitinib citrate) approval

Efficacy supplement (new or revised indication). tablet, oral. Sponsor: Pf Prism Cv

4 takeaways from the AAFP’s response to the 2026 MPFS proposed rule

Episode 239 -- October 2025 -- Part 1 AFP: American Family Physician

Uterine fibroids (1:30), community-based residency training (6:40), glucagon-like peptide-1 medications (9:00), heart failure with preserved ejection fraction (12:30), intravenous vs oral iron (15:40), nicotine e-cigarettes for smoking cessation (18:10), and spooky health trends—are they real or fake? (20:10; music: Tocatta and Fugue in D Minor, Kevin MacLeod, CC-BY-3.0).